Cargando…

Comparative genomic analysis of esophageal squamous cell carcinoma and adenocarcinoma: New opportunities towards molecularly targeted therapy

Esophageal cancer is one of the most lethal cancers worldwide because of its rapid progression and poor prognosis. Esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC) are two major subtypes of esophageal cancer. ESCC predominantly affects African and Asian populations, whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xu, Wang, Yuxiang, Meng, Linghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069403/ https://www.ncbi.nlm.nih.gov/pubmed/35530133 http://dx.doi.org/10.1016/j.apsb.2021.09.028

Ejemplares similares

Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma
por: Yasar, Hatime A
Publicado: (2023)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
por: Li, Xianfeng, et al.
Publicado: (2023)

Esophageal Adenocarcinoma: Opportunities for Targeted Prevention in Ohio
por: Stephens, Julie A, et al.
Publicado: (2018)

Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma
por: Ooki, Akira, et al.
Publicado: (2023)

Genomic and molecular characterization of esophageal squamous cell carcinoma
por: Lin, De-Chen, et al.
Publicado: (2014)

Archaea Microbiome Dysregulated Genes and Pathways as Molecular Targets for Lung Adenocarcinoma and Squamous Cell Carcinoma
por: Uzelac, Matthew, et al.
Publicado: (2022)

A comparative Analysis by SAGE of Gene Expression Profiles of Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma
por: van Baal, Jantine W. P. M., et al.
Publicado: (2008)

Targeted Molecular Therapies in the Treatment of Esophageal Adenocarcinoma, Are We There Yet?
por: Khalafi, Shayan, et al.
Publicado: (2020)

Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2021)

Immune checkpoint inhibitors in esophageal squamous cell carcinoma: progress and opportunities
por: Jiao, Ruidi, et al.
Publicado: (2019)

The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies
por: Testa, Ugo, et al.
Publicado: (2023)

Drivers of Esophageal Adenocarcinoma and Opportunities for Cancer Interception
por: Garman, Katherine S.
Publicado: (2021)

Interleukin-6 as a potential molecular target in esophageal squamous cell carcinoma
por: ZHAO, ZHI-FEI, et al.
Publicado: (2016)

Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy
por: Zhao, Xiaojuan, et al.
Publicado: (2021)

Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques
por: Bellini, Marilanda Ferreira, et al.
Publicado: (2010)

Simultaneous Esophageal Squamous Cell Carcinoma and Adenocarcinoma: A Case Report
por: Maleki, Iradj, et al.
Publicado: (2015)

Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma
por: Zhang, Guoqing, et al.
Publicado: (2019)

Mitochondrial DNA deletions in patients with esophagitis, Barrett's esophagus, esophageal adenocarcinoma and squamous cell carcinoma
por: Keles, Muzaffer, et al.
Publicado: (2019)

Adjuvant Therapy for Esophageal Squamous Cell Carcinoma
por: Sun, Jong-Mu
Publicado: (2020)

PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy
por: Luo, Qian, et al.
Publicado: (2022)

An esophageal squamous cell carcinoma classification system that reveals potential targets for therapy
por: Xiong, Teng, et al.
Publicado: (2017)

Simvastatin, but not pravastatin, inhibits the proliferation of esophageal adenocarcinoma and squamous cell carcinoma cells: a cell-molecular study
por: Chen, Yan, et al.
Publicado: (2018)

Comparative genomic analysis of esophageal squamous cell carcinoma among different geographic regions
por: Zhang, Ruixiang, et al.
Publicado: (2023)

Trends in Esophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma Incidence in the United States from 1992 to 2019
por: Liu, Kyle S., et al.
Publicado: (2022)

Prognostic significance of NFIA and NFIB in esophageal squamous carcinoma and esophagogastric junction adenocarcinoma
por: Yang, Bo, et al.
Publicado: (2018)

Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma
por: Zhang, Ling, et al.
Publicado: (2020)

Defining conversion therapy for esophageal squamous cell carcinoma
por: Matsuda, Satoru, et al.
Publicado: (2022)

Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors
por: Zhang, Xu, et al.
Publicado: (2023)

Gene Expression in Barrett’s Esophagus Cell Lines Resemble Esophageal Squamous Cell Carcinoma Instead of Esophageal Adenocarcinoma
por: Panda, Anshuman, et al.
Publicado: (2021)

Genomic and epigenomic evolution of acquired resistance to combination therapy in esophageal squamous cell carcinoma
por: Min, Qingjie, et al.
Publicado: (2021)

Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations
por: Deng, Jiaying, et al.
Publicado: (2017)

Clinicopathologic characteristics of high expression of Bmi-1 in esophageal adenocarcinoma and squamous cell carcinoma
por: Choy, Bonnie, et al.
Publicado: (2012)

Esophageal Carcinoma with Triplicate Differentiation into Squamous Cell Carcinoma, Small Cell Carcinoma and Adenocarcinoma: a Case Report
por: Terada, Tadashi
Publicado: (2009)

Targeting ornithine decarboxylase (ODC) inhibits esophageal squamous cell carcinoma progression
por: He, Wei, et al.
Publicado: (2017)

Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma
por: Li, Yi, et al.
Publicado: (2021)

Genomic and transcriptional characterization of early esophageal squamous cell carcinoma
por: Zhao, Jingjing, et al.
Publicado: (2023)

Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma
por: Huai, Qilin, et al.
Publicado: (2021)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Targeting valosin‐containing protein enhances the efficacy of radiation therapy in esophageal squamous cell carcinoma
por: Luo, Hui, et al.
Publicado: (2019)

Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy
por: Xu, Jia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bl3n3se7t8n6crtte0elau985q